Blog

TARGETING B-RAF KINASE IN MELANOMA

TRASTUZUMAB-DM1 FOR HER-2 POSITIVE METASTATIC BREAST CANCER

TREATING ADVANCED THYROID CANCER WITH PROTEIN KINASE INHIBITORS

Overcoming Resistance to Tyrosine Kinase Inhibitors in CML

p-53 INDEPENDENT TRAIL-INDUCTION TRIGGERS TUMOR CELL DEATH

Epithelial to Mesenchymal Transition: the Key to Cancer Metastasis

Multidrug-Resistance in Cancer: ABC-Transporters

Cancer Stem Cell Hypothesis: Proceed with Caution

Histone Deacetylase Inhibitors: A New Treatment Option in Cancer